Erratum: Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections (Journal of Interventional Cardiac Electrophysiology (2011) 31:2 (171-183) DOI: 10.1007/s10840-010-9537-x);Risk factors associated with early-versus late-onset implantable cardioverter-defibrillator infections

Journal of Interventional Cardiac Electrophysiology

Volumn 31, Issue 2, 2011, Pages 171-183

  Sohail, Muhammad R ^a   Hussain, Salwa ^a   Le, Katherine Y ^b   Dib, Chadi ^c   Lohse, Christine M ^a   Friedman, Paul A ^a   Hayes, David L ^a   Uslan, Daniel Z ^d   Wilson, Walter R ^a   Steckelberg, James M ^a   Baddour, Larry M ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ICD; Implantable cardioverter defibrillator; Infection; Risk factor

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; FEMALE; HOSPITALIZATION; HUMAN; INFECTION RATE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS;

EID: 80053563768     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-012-9730-1     Document Type: Erratum

References (31)

1. Sohail, M. R., Sultan, O. W., & Raza, S. S. (2010). Contemporary management of cardiovascular implantable electronic device infections. Expert Review of Anti-Infective Therapy, 8(7), 831-839
2. Epstein, A. E., Dimarco, J. P., Ellenbogen, K. A., et al. (2008). ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm, 5(6), e1-62
3. Voigt, A., Shalaby, A., & Saba, S. (2006). Rising rates of cardiac rhythm management device infections in the United States: 1996 through2003. Journal of the American College of Cardiology, 48 (3), 590-591 (Pubitemid 44093958)
4. Cabell, C. H., Heidenreich, P. A., Chu, V. H., et al. (2004). Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. American Heart Journal, 147(4), 582-586 (Pubitemid 38900441)
5. Uslan, D. Z., Sohail, M. R., St Sauver, J. L., et al. (2007). Permanent pacemaker and implantable cardioverter defibrillator infection: A population-based study. Archives of Internal Medicine, 167(7), 669-675 (Pubitemid 46598459)
6. Sohail, M. R., Uslan, D. Z., Khan, A. H., et al. (2007). Risk factor analysis of permanent pacemaker infection. Clinical Infectious Diseases, 45(2), 166-173 (Pubitemid 47041006)
7. Klug, D., Balde, M., Pavin, D., et al. (2007). Risk factors related to infections of implanted pacemakers and cardioverterdefibrillators: Results of a large prospective study. Circulation, 116(12), 1349-1355 (Pubitemid 47417560)
8. Mela, T., McGovern, B. A., Garan, H., et al. (2001). Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. The American Journal of Cardiology, 88(7), 750-753
9. Lekkerkerker, J. C., van Nieuwkoop, C., Trines, S. A., et al. (2009). Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart (British Cardiac Society), 95(9), 715-720
10. Bloom, H., Heeke, B., Leon, A., et al. (2006). Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing and Clinical Electrophysiology, 29(2), 142-145
11. Johansen, J. B., Nielsen, J. C., Arnsbo, P., Moller, M., Pedersen, A. K., & Mortensen, P. T. (2006). AB49-5: Higher incidence of pacemaker infection after replacement than after first implantation: Experiences from 36, 076 consecutive patients. Heart Rhythm, 3(5 Supplement 1), S102-S103
12. Al-Khatib, S. M., Lucas, F. L., Jollis, J. G., Malenka, D. J., & Wennberg, D. E. (2005). The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. Journal of the American College of Cardiology, 46(8), 1536-1540 (Pubitemid 41446191)
13. Sohail, M. R., Wilson, W. R., & Baddour, L. M. (2010). Infections of nonvalvular cardiovascular devices. In G. L. Mandell, J. E. Bennett, & R. Dolin (Eds.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, vol. I (pp. 1127- 1142). Philadelphia: Churchill Livingstone
14. Uslan, D. Z., Dowsley, T. F., Sohail, M. R., et al. (2010). Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing and Clinical Electrophysiology, 33, 407-413
15. Sohail, M. R., Uslan, D. Z., Khan, A. H., et al. (2007). Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. Journal of the American College of Cardiology, 49(18), 1851-1859 (Pubitemid 46661104)
16. Thal, S., Moukabary, T., Boyella, R., et al. (2010). The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation. Pacing and Clinical Electrophysiology, 33(4), 385-388
17. de Bono, J., Nazir, S., Ruparelia, N., Bashir, Y., Betts, T., & Rajappan, K. (2010). Perioperative management of anticoagulation during device implantation - The UK perspective. Pacing and Clinical Electrophysiology, 33(4), 389-393
18. Tolosana, J. M., Berne, P., Mont, L., et al. (2009). Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: Oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. European Heart Journal, 30(15), 1880-1884
19. Jamula, E., Douketis, J. D., & Schulman, S. (2008). Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: A systematic review and practical management guide. Journal of Thrombosis and Haemostasis, 6(10), 1615-1621
20. Ahmed, I., Gertner, E., Nelson, W. B., et al. (2010). Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm, 7(6), 745-749
21. Cheng, M., Hua, W., Chen, K., et al. (2009). Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation. Europace, 11(9), 1183-1187
22. Daubert JC, Mabo P. Continue or withhold oral anticoagulation in high-risk patients undergoing pacemaker or ICD implantation. European heart journal. Aug 282009.
23. Love, C. J. (2010). Perioperative management of anticoagulation in patients undergoing cardiac rhythm device procedures: A bridge to nowhere? Pacing and Clinical Electrophysiology, 33 (4), 383-384
24. Douketis, J. D., Berger, P. B., Dunn, A. S., et al. (2008). The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133(6 Suppl), 299S-339S (Pubitemid 351894915)
25. H.K. Li, F.C. Chen and R.F. Rea et al., Safety of continuing warfarin in patients who undergo device-related procedure, Heart Rhythm 6 (Suppl 1) (2009), p. MP044
26. Trappe, H. J., Pfitzner, P., Klein, H., & Wenzlaff, P. (1995). Infections after cardioverter-defibrillator implantation: Observations in 335 patients over 10 years. British Heart Journal, 73(1), 20-24
27. Lai, K. K., & Fontecchio, S. A. (1998). Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: Epidemiology, infection control, and management. Clinical Infectious Diseases, 27(2), 265-269
28. de Oliveira, J. C., Martinelli, M., Nishioka, S. A., et al. (2009). Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: Results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circulation: Arrhythmia and Electrophysiology, 2(1), 29-34
29. Da Costa, A., Kirkorian, G., Cucherat, M., et al. (1998). Antibiotic prophylaxis for permanent pacemaker implantation: A meta-analysis. Circulation, 97(18), 1796-1801 (Pubitemid 28213623)
30. Sohail, M. R., Uslan, D. Z., Khan, A. H., et al. (2008). Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clinic Proceedings, 83 (1), 46-53
31. Borleffs, C. J. W., Thijssen, J., de Bie, M. K., et al. (2010). Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing and Clinical Electrophysiology, 33(8), 1013-1019.